Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis. (Q40385043)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

Massimiliano Mirabella

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Caggiula M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Batocchi AP

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Frisullo G

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Angelucci F

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Patanella AK

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sancricca C

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Nociti V

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Tonali PA

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

1 reference

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Immunology

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

176-182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16101825%20AND%20SRC:MED&resulttype=core&format=json

The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X

Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X

Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X

Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X

Time-course changes of nerve growth factor, corticotropin-releasing hormone, and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X

Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X

The influence of inhalative corticosteroids on circulating Nerve Growth Factor, Brain-Derived Neurotrophic Factor and Neurotrophin-3 in allergic asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X

Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X

Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01649.X